U.S. Markets open in 3 hrs 17 mins

The Zacks Analyst Blog Highlights: Altria, Coca-Cola, PepsiCo, Constellation and Canopy Growth

Zacks Equity Research
Minerva Neurosciences has been struggling lately, but the selling pressure may be coming to an end soon.

For Immediate Release

Chicago, IL –October 17, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Altria Group Inc. MO, Coca-Cola Company KO, PepsiCo PEP, Constellation Brands STZ and Canopy Growth Corp. CGC.

Here are highlights from Tuesday’s Analyst Blog:

Cannabis Market Attracts Cigarette Makers

Altria Group Inc., America’s leading cigarette manufacturer, is in talks with Canadian cannabis producer Aphria Inc. to buy a stake in it, The Globe & Mail reported last week.

Altria, parent of Marlboro cigarette-maker Philip Morris USA, is making the move at a time when Canada is set to legalize recreational marijuana on Oct 17.

This could be one of the reasons why many consumer goods’ manufacturers, food and beverage giants are trying to partner with Canadian cannabis growers in recent months.

Marijuana’s Benefits and Market Growth Opportunities Entice Cigarette Makers

The marijuana industry is expected to reach $146.4 billion by 2025 end, at a compound annual growth rate of 34.6%, according to Grand View Report. This could be prompting American cigarette manufacturers to seek an entry into the booming cannabis market.

The legalization of medical and recreational marijuana could offer unlimited options in terms of newly formulated products that could attract health-conscious consumers.

Smoking marijuana for medical purposes has been legal across 29 states in the United States since January while recreational marijuana is legal in 9 states.

Benefits of medical marijuana include curing and preventing eye diseases such as Glaucoma, controlling epileptic seizures, decreasing anxiety, easing pain induced by arthritis etc.

Marijuana-infused beverages and food products captured the attention of major American giants such as Coca-Cola Company and PepsiCo. Earlier this year, these two companies announced their interest in preparing cannabidiol-infused products. Cannabidiol (CBD) is a non-psychotropic drug found in the cannabis plant and its benefits include curing seizures, reducing inflammation, preventing cancer from spreading rapidly and decreasing pain.

Major Investments Promise Solid Growth Prospects

Marijuana stocks have witnessed an uptick in their prices since mid-August when Constellation Brands confirmed it plans to invest an additional $4 billion in Canada’s Canopy Growth Corp. The Corona beer maker had acquired a 9.9% stake in Canopy Growth in October 2017.

Not a month later, Coca-Cola expressed its interest to invest in Aurora Cannabis. This was followed by PepsiCo’s inclination toward making investments in the marijuana industry. While Coke and Pepsi could be eyeing new food and beverage products, Altria’s plans to formulate new consumables in place of its classic cigars remain to be seen.

The increasingly changing preferences of consumers and the legalization of cannabis across Canada and many states in the U.S. indicate solid growth prospects for the Marijuana-exposed stocks.

You can seethe complete list of today’s Zacks #1 Rank stocks here.

The Hottest Tech Mega-Trend of All                 

Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks' 3 Best Stocks to Play This Trend >>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com                                      

https://www.zacks.com                                                   

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Constellation Brands Inc (STZ) : Free Stock Analysis Report
 
Pepsico, Inc. (PEP) : Free Stock Analysis Report
 
Coca-Cola Company (The) (KO) : Free Stock Analysis Report
 
Altria Group, Inc. (MO) : Free Stock Analysis Report
 
Canopy Growth Corporation (CGC) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research